UPDATE -- Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., May 10, 2017 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. MNTA, a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentation at two upcoming investor conferences.

Bank of America Merrill Lynch 2017 Health Care Conference

Wednesday, May 17, 2017 at 12:20 p.m. ET in Las Vegas, NV

UBS Global Healthcare Conference

Tuesday, May 23, 2017 at 9:00 a.m. ET in New York, NY

A webcast of each presentation will be available live on the "Investors" section of the company's website located at www.momentapharma.com.  A replay of each presentation will be posted on the Momenta website approximately one hour after each event.

About Momenta

Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for autoimmune indications.

To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.

Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.

Contact: 
Sarah Carmody
Momenta Pharmaceuticals
1-617-395-5189
IR@momentapharma.com